WorldCat Identities

Günaydın, Zeki Yüksel

Works: 4 works in 4 publications in 1 language and 4 library holdings
Publication Timeline
Most widely held works by Zeki Yüksel Günaydın
Relationship Between Red Cell Distribution Width and Stroke in Patients With Stable Chronic Heart Failure( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Aim: We aimed to investigate the association between baseline red cell distribution width (RDW) level and the risk of stroke in patients with heart failure (HF). Methods: A total of 153 consecutive patients with HF (New York Heart Association [NYHA] I-III and left ventricular ejection fraction of <40%) were included in this prospective study. All the patients were followed up for 1 year, and during this period the cerebrovascular disease was questioned. Results: In matched population, using propensity score matching comparing patients with HF having stroke with patients without stroke, we found significantly increased basal RDW and serum uric acid. The receiver-operating characteristic curves of RDW for predicting stroke are performed. An RDW e"5.2% measured on admission had 87% sensitivity and 74% specificity in predicting stroke in patients with HF (area under the curve: 0.923, 95% confidence interval: 0.852-0.994, P <.001). Conclusion: In conclusion, this study demonstrated that RDW may be important hematological indices for stroke in patients with HF using propensity score analysis
Does Trastuzumab cause permanent severe mitral regurgitation?( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

Abstract : Background: No-reflow is associated with a poor prognosis in STEMI patients. There are many factors and mechanisms that contribute to the development of no-reflow, including age, reperfusion time, a high thrombus burden, Killip class, long stent use, ejection fraction d"0, and a high Syntax score. In this study, we aimed to evaluate the parameters associated with no-reflow prediction by creating a new scoring system. Methods: The study included 515 consecutive STEMI patients who underwent PCI; 632 STEMI patients who had undergone PCI in another center were included in the external validation of the scoring system. The correlations between 1-year major adverse cardiac events and low/high risk score were assessed. Results: In this study, seven independent variables were used to build a risk score for predicting no-reflow. The predictors of no-reflow are age, EF d"0, SS e"2, stent length e"0, thrombus grade e", Killip class e", and pain-balloon time e" h. In the derivation group, the optimal threshold score for predicting no-reflow was>10, with a 75% sensitivity and 77.7% specificity (Area under the curve (AUC) = 0.809, 95%CI: 0.772-0.842, P <0.001). In the validation group, AUC was 0.793 (95%CI: 0.760-0.824, P <0.001). Conclusion: This new score, which can be calculated in STEMI patients before PCI and used to predict no-reflow in STEMI patients, may help physicians to estimate the development of no-reflow in the pre-PCI period
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.88 (from 0.88 for Does Trast ... to 0.88 for Does Trast ...)